MedTrace Logo

Study on the Health Economic Burden of Alzheimer's Disease in China

NCT05995418 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 9510

Last updated 2026-06-05

No results posted yet for this study

Summary

Alzheimer's disease (AD) presents a significant socio-economic challenge globally, with China experiencing a notable rise in its prevalence. This study addresses critical gaps in understanding AD's economic burden and quality of life (QoL) impacts on patients and caregivers in Mainland China.

Conditions

Interventions

OTHER

There was no intervention as this was an observational study.

There was no intervention as this was an observational study.

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2026-06-30
Completion
2027-01-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05995418 on ClinicalTrials.gov